Feasibility and safety of a fully covered self-expandable metal stent with antimigration properties for EUS-guided pancreatic duct drainage: early and midterm outcomes (with video)
| Autor: | Tae Jun Song, Sang Soo Lee, Dong Wan Seo, Do Hyun Park, Kwangwoo Nam, Sung Koo Lee, Dongwook Oh, Min Keun Cho, Myung-Hwan Kim |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Male medicine.medical_specialty Abdominal pain Time Factors medicine.medical_treatment Self Expandable Metallic Stents Constriction Pathologic Prosthesis Design law.invention Endosonography 03 medical and health sciences 0302 clinical medicine Randomized controlled trial Interquartile range Self-expandable metallic stent law Pancreatitis Chronic medicine Humans Radiology Nuclear Medicine and imaging Pancreatitis chronic Adverse effect Aged Retrospective Studies business.industry Gastroenterology Pancreatic Ducts Stent Middle Aged medicine.disease digestive system diseases Surgery Treatment Outcome Surgery Computer-Assisted 030220 oncology & carcinogenesis Pancreatitis Drainage 030211 gastroenterology & hepatology Female Radiology medicine.symptom business Follow-Up Studies |
| Zdroj: | Gastrointestinal endoscopy. 83(2) |
| ISSN: | 1097-6779 |
| Popis: | Background and Aims Recently, EUS-guided pancreatic duct drainage (EUS-PD) has been used for patients in whom endoscopic retrograde pancreatography (ERP) has failed. Stent-related adverse events such as stent migrations, failures in stent placement, or pancreatic fluid leakages have been of concern in transmural plastic stenting procedures. The aim of this study is to evaluate the feasibility and safety of EUS-PD with a fully covered self-expandable metal stent (FCSEMS) for patients with obstructive pancreatitis who failed ERP. Methods Twenty-five consecutive patients with painful obstructive pancreatitis underwent EUS-PD with a FCSEMS after failed ERP. Technical and clinical success, adverse events, and stent patency were assessed. Results EUS-PD was successful in all 25 patients (technical success rate, 100%), and symptoms improved in all patients (clinical success rate, 100%). EUS-guided pancreaticogastrostomy (n = 23), pancreaticoduodenostomy (n = 1), and pancreaticojejunostomy (n = 1) were performed. Pain scores improved significantly after FCSEMS placement ( P = .001). Early mild grade adverse events occurred in 5 patients (20%), 4 with self-limited abdominal pain and 1 with minor bleeding. No other adverse events related to FCSEMS, including stent migration, stent clogging, pancreatic sepsis, and stent-induced ductal stricture, were observed during follow-up periods. Mean stent patency duration was 126.9 days during mean follow-up periods (221.1 days). Conclusions EUS-PD with an FCSEMS may be technically feasible and relatively safe for patients who fail conventional ERP. Further randomized trials comparing EUS-PD with long-term FCSEMS and plastic stents for patients with painful obstructive pancreatitis after failed ERCP should be encouraged. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect